Zimmer Biomet (NYSE: ZBH) exec vests 9,957 RSUs, with 4,266 shares withheld
Rhea-AI Filing Summary
ZIMMER BIOMET HOLDINGS executive Kevin R. Thornal exercised 9,957 Restricted Stock Units into 9,957 shares of common stock on August 1, 2026. To satisfy tax obligations on this RSU vesting, 4,266 shares were withheld at $92.68 per share. Following the transaction, Thornal held 19,913 RSUs, with the remaining units scheduled to vest half on August 1, 2027 and half on August 1, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,691 shares
Net Buy
3 txns
Insider
Thornal Kevin R
Role
Grp Pres-Global Business
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2, F3 | 9,957 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,957 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F1 | 4,266 | $92.68 | $395K |
Holdings After Transaction:
Restricted Stock Units — 19,913 shares (Direct);
Common Stock — 5,691 shares (Direct)
Footnotes (3)
- F1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
- F2. Each RSU represents a contingent right to receive one share of Company common stock.
- F3. One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.
Key Figures
RSUs converted: 9957.0000 units
Common shares acquired from RSUs: 9957.0000 shares
Shares withheld for taxes: 4266.0000 shares
+2 more
5 metrics
RSUs converted
9957.0000 units
Restricted Stock Units converted into common stock on August 1, 2026
Common shares acquired from RSUs
9957.0000 shares
Shares of common stock received upon RSU vesting and conversion on August 1, 2026
Shares withheld for taxes
4266.0000 shares
Common shares withheld to satisfy tax withholding obligations on RSU vesting
Tax withholding price
92.6800 per share
Per-share value used for shares withheld for tax obligations
RSUs remaining after transaction
19913.0000 units
Restricted Stock Units held after August 1, 2026 vesting event
Key Terms
Restricted Stock Units, tax withholding obligations, contingent right, vesting
4 terms
Restricted Stock Units financial
"security title "Restricted Stock Units" reported for the RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares withheld by the Company to satisfy tax withholding obligations"
contingent right financial
"Each RSU represents a contingent right to receive one share"
vesting financial
"One-third of the RSUs vested on August 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider activity did Kevin R. Thornal report for Zimmer Biomet (ZBH)?
Kevin R. Thornal reported exercising 9,957 Restricted Stock Units into 9,957 shares of Zimmer Biomet common stock. To cover tax obligations from this vesting, 4,266 shares were withheld by the company at a price of $92.68 per share.
How many ZBH Restricted Stock Units vested and converted to common stock?
On August 1, 2026, 9,957 RSUs vested and were converted into 9,957 shares of Zimmer Biomet common stock for Kevin R. Thornal. Each RSU represented a contingent right to receive one share of company common stock upon vesting.
What RSU vesting schedule remains for Kevin R. Thornal at Zimmer Biomet (ZBH)?
After the August 1, 2026 vesting, Kevin R. Thornal held 19,913 RSUs outstanding. The remaining RSUs are scheduled to vest in two equal installments, with one-half vesting on August 1, 2027 and one-half vesting on August 1, 2028.
Were Kevin R. Thornal’s ZBH transactions made under a Rule 10b5-1 plan?
The report indicates these transactions were not made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is marked as false, meaning the insider did not affirm that a pre-arranged trading plan governed these transactions.
What is Kevin R. Thornal’s role at Zimmer Biomet (ZBH) in this Form 4?
Kevin R. Thornal is reported as an officer of Zimmer Biomet, serving as Grp Pres-Global Business. The Form 4 reflects equity compensation activity related to his role, specifically RSU vesting, conversion into common stock, and associated tax withholding in company shares.